Latest filing published 18 Jul 2025 for Organogenesis Holdings Inc., €1,381.
Insider track record
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Robert Cavorsi: trading record in brief
Robert Cavorsi appears in our data through filings on Organogenesis Holdings Inc. shares, published by SEC (Form 4). We count 17 filings; the first trade dates from 16 July 2024 and the latest from 1 March 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 3 March 2026, the filings show a share grant worth €18k in Organogenesis Holdings Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert Cavorsi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 360 shares@ US$4.465Class A Common StockSEC:0001062993-25-012995:0
- 210 shares@ US$5.164.3% of flowClass A Common StockSEC:0001062993-25-005250:0
- 667 shares@ US$6.2116.9% of flowClass A Common StockSEC:0001062993-25-004351:0
- 61,705 shares0Class A Common StockSEC:0001062993-25-003235:0
- 5,000 shares@ US$3.7075.0% of flowClass A Common StockSEC:0001062993-25-002940:0
- 317 shares@ US$3.093.8% of flowClass A Common StockSEC:0001062993-24-013923:0
6 of 6 declarations
